Terminalia chebula Fruit Extract Ameliorates Peripheral Edema by Inhibiting NF-κB and MAPK Signaling Pathways
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26209965 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sang-Hyup Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: NUON Co., Ltd., Seongnam 13201, Republic of Korea. Hauptthemen laut MEDLINE: NF-kappa B, Plant Extracts, Edema, Terminalia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Peripheral edema is a pathological condition caused by abnormal fluid accumulation in the interstitial space due to elevated vascular permeability and inflammation. This study evaluated the therapeutic efficacy of Terminalia chebula fruit extract (TCE) in inflammation-induced peripheral edema and clarified its molecular mechanisms. Using hydrogen peroxide (H2O2)-stimulated human umbilical vein endothelial cells (HUVECs), TCE was tested for effects on cell viability, inflammatory gene expression, intracellular reactive oxygen species, endothelial barrier integrity, and vascular endothelial growth factor (VEGF)-induced migration. Its influence on nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and mitogen-activated protein kinase (MAPK) signaling was examined. In vivo, TCE was assessed in acetic acid-induced peritoneal vascular permeability and carrageenan-induced paw edema models, followed by histological analysis and serum tumor necrosis factor-α (TNF-α) measurement. TCE restored cell viability (76.2% to 94.8%), reduced TNF, IL6, and PTGS2 mRNA expression, and decreased reactive oxygen species by 27.2%. It enhanced barrier integrity, increased transendothelial electrical resistance, and inhibited VEGF-induced migration. TCE suppressed NF-κB and MAPK activation. In vivo, TCE reduced Evans blue extravasation by 41.6% and paw edema by 67.5%. Histology showed reduced dermal thickening and inflammatory infiltration, and serum TNF-α levels were lowered. TCE attenuates peripheral edema by preserving endothelial barrier function and suppressing inflammatory signaling, supporting its potential as a therapeutic agent for inflammation-associated vascular dysfunction and edema.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NUON Co., Ltd., Seongnam 13201, Republic of Korea.
- BK21 FOUR Program, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea.
ORCID-Profile: Ji-Soo Jeong, Je-Won Ko, Tae-Won Kim
Zitieren
APA
Lee, S. H., Kim, S. Y., Gwon, Y. G., Lee, S. H., Jeong, J. S., Ko, J. W., Kim, T. W., & Choi, B. K. (2025). Terminalia chebula Fruit Extract Ameliorates Peripheral Edema by Inhibiting NF-κB and MAPK Signaling Pathways. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26209965
Vancouver
Lee SH, Kim SY, Gwon YG, Lee SH, Jeong JS, Ko JW, et al. Terminalia chebula Fruit Extract Ameliorates Peripheral Edema by Inhibiting NF-κB and MAPK Signaling Pathways. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26209965
BibTeX
@article{Lee2025,
author = {Lee, Sang-Hyup and Kim, Sang-Yoon and Gwon, Yun-Gu and Lee, Su-Ha and Jeong, Ji-Soo and Ko, Je-Won and Kim, Tae-Won and Choi, Bong-Keun},
title = {Terminalia chebula Fruit Extract Ameliorates Peripheral Edema by Inhibiting NF-κB and MAPK Signaling Pathways},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26209965}
}
EUVIMED